LATEST
Gaza’s Winter Emergency Exposes the Failure to Enforce the CeasefireAustralian Journalist Accuses Media Giants of Shielding Israel and Silencing Palestinian Voices186,000 Arabic Posts Flagged, Five in Hebrew: The Fight Over Gaza’s Public RecordAs Gaza’s Tents Flood and Claim Young Lives, Israel's Channel 14 Turns Palestinian Suffering into a Water Park JokeSecret UK Arms Files Reveal Wartime Exports and Unanswered Questions Over Israel RestrictionsTO THE NEW Joins SpaceX Super Intelligence Partner Network to Scale AI-Assisted DevelopmentNobel Peace Prize Laureate Urges Israelis to Act Over Gaza Genocide as American Jewish Dissent DeepensTerry Dubrow: “You Can’t Trust Every Company Selling GLP-1 Drugs Online.” So He Founded One.Pia and Joshua Filler Introduce KillerFillers Jump, Break, and Jump/Break Tip Line Developed with TitlistA2C and Andrea Pusateri Bring “Here for the Ride” to Sardinia for a Five-Stage Grand Loop Cycling ChallengeGaza’s Winter Emergency Exposes the Failure to Enforce the CeasefireAustralian Journalist Accuses Media Giants of Shielding Israel and Silencing Palestinian Voices186,000 Arabic Posts Flagged, Five in Hebrew: The Fight Over Gaza’s Public RecordAs Gaza’s Tents Flood and Claim Young Lives, Israel's Channel 14 Turns Palestinian Suffering into a Water Park JokeSecret UK Arms Files Reveal Wartime Exports and Unanswered Questions Over Israel RestrictionsTO THE NEW Joins SpaceX Super Intelligence Partner Network to Scale AI-Assisted DevelopmentNobel Peace Prize Laureate Urges Israelis to Act Over Gaza Genocide as American Jewish Dissent DeepensTerry Dubrow: “You Can’t Trust Every Company Selling GLP-1 Drugs Online.” So He Founded One.Pia and Joshua Filler Introduce KillerFillers Jump, Break, and Jump/Break Tip Line Developed with TitlistA2C and Andrea Pusateri Bring “Here for the Ride” to Sardinia for a Five-Stage Grand Loop Cycling Challenge
Business

Updated URL to Access ProMIS Annual Meeting of Shareholders on June 29, 2023 at 9:30am Eastern Time

ProMIS Neurosciences Inc. (TSX: PMN) (NASDAQ: PMNRFXF) (“ProMIS” or the “Corporation”) is issuing this release to correct the URL required to virtually access the Corporation’s Annual Meeting of Shareholders included in the Corporation’s Definitive Proxy Statement filed with the SEC and on SEDAR on June 1, 2023. 

 

The corrected URL is: http://www.virtualshareholdermeeting.com/PMN2023

  Please use the corrected URL to access the Annual Meeting of Shareholders, which begins on June 29, 2023 at 9:30am Eastern Time.  All other information included in the Definitive Proxy Statement remains unchanged.  

ProMIS Neurosciences Inc. is a development stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. The Company’s proprietary target discovery engine applies a thermodynamic, computational discovery platform - ProMIS and Collective Coordinates - to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this unique approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. ProMIS has offices in Toronto, Ontario and Cambridge, Massachusetts. ProMIS is listed on Nasdaq and the Toronto Stock Exchange under the symbol PMN.

 

http://www.promisneurosciences.com

Related articles

Top